Significance. The Acute Respiratory Distress Syndrome (ARDS) is responsible for significant morbidity and mortality. Aside from lung protective mechanical ventilation strategies and conservative fluid management, there are no specific therapies for ARDS. A hallmark of ARDS is injury to the alveolar epithelium, including cell death, primarily of alveolar type (AT) I cells, resulting in permeability and the influx of edma fluid, which in turn leads to refractory hypoxemia. This injury phase is followed by a reparative response during which surviving ATII cells spread onto the denuded basement membrane, proliferate, and transdifferentiate into ATI cells, thus restoring barrier integrity. Importantly, epithelial repair is a primary determinant of recovery from ARDS. Innovation. Historically, basic ARDS research has focused on the injury phase; unfortunately, therapeutic interventions designed to mitigate injury have generally been unsuccessful. Investigations into reparative mechanisms have explored ATII cell proliferation. In this proposal, we focus on ATII cell spreading onto the denuded basement membrane after the sloughing of ATI cells. This phenomenon has been recognized since the 1970s but has not been well studied in animal models. We define spreading as an increase in surface area resulting in increased coverage of the denuded basement membrane. We have developed a novel method to rigorously measure spreading of genetically-labeled ATII cells using stringent stereologic techniques. We will characterize ATII cell spreading after mild and severe injury in relationship to proliferation, transdifferentiation, and the restitution of barrier integrity. Hypothesis. Based on our preliminar data, we hypothesize that Hypoxia Inducible Factor (HIF) 1? promotes ATII cell spreading and the restitution of barrier integrity via CXCR4/SDF1 signaling. Research Plan.
Aim 1 will test whether in limited lung injury, rapid, pre-mitotic ATII cell spreading is associated with barrier restoration; in addition, after severe injury, requiring proliferation to replace lost cells, whethr post-mitotic spreading correlates with barrier restoration.
Aim 2 will determine whether HIF1? is critical for spreading.
Aim 3 will test the hypothesis that CXCR/SDF1 signaling promotes and mediates the role of HIF1? in ATII cell spreading. We will use both gain- and loss-of-function techniques, including ATII cell specific gene deficient mice. Our primary readout will be morphometric measurement of spreading (area of alveolar surface covered) using stereologic techniques. We will directly link in vivo studies to mechanistic spreading assays in cultured primary ATII cells. Conclusion. Here, we study repair of the injured alveolar epithelium by ATII cell spreading with an emphasis on the restitution of epithelial barrier integrity, a highly cliniclly relevant outcome. These studies will identify novel therapeutic targets to accelerate epithelial repair in ARDS, ultimately promoting the resolution of pulmonary edema and clinical recovery.

Public Health Relevance

The Acute Respiratory Distress Syndrome (ARDS) is responsible for significant morbidity, mortality (20-50%), and health care costs; therapeutic options are limited. Recovery from ARDS is dependent on repair of the cells that line the air sacs of the lung (epithelial cells). We propose to study the mechanisms by which epithelial cells repair with the goal of identifying specific targets for therapies to hasten recovery from this devastating disorder

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
7R01HL131608-03
Application #
9530985
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Craig, Matt
Project Start
2016-04-01
Project End
2021-03-31
Budget Start
2017-08-25
Budget End
2018-03-31
Support Year
3
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ravi Kumar, Sangeetha; Paudel, Sagar; Ghimire, Laxman et al. (2018) Emerging Roles of Inflammasomes in Acute Pneumonia. Am J Respir Crit Care Med 197:160-171
Correll, Kelly A; Edeen, Karen E; Zemans, Rachel L et al. (2018) TGF beta inhibits expression of SP-A, SP-B, SP-C, but not SP-D in human alveolar type II cells. Biochem Biophys Res Commun 499:843-848
Jansing, Nicole L; McClendon, Jazalle; Henson, Peter M et al. (2017) Unbiased Quantitation of Alveolar Type II to Alveolar Type I Cell Transdifferentiation during Repair after Lung Injury in Mice. Am J Respir Cell Mol Biol 57:519-526
Zemans, Rachel L; Jacobson, Sean; Keene, Jason et al. (2017) Multiple biomarkers predict disease severity, progression and mortality in COPD. Respir Res 18:117
McClendon, Jazalle; Jansing, Nicole L; Redente, Elizabeth F et al. (2017) Hypoxia-Inducible Factor 1? Signaling Promotes Repair of the Alveolar Epithelium after Acute Lung Injury. Am J Pathol 187:1772-1786
Neudecker, Viola; Brodsky, Kelley S; Clambey, Eric T et al. (2017) Neutrophil transfer of miR-223 to lung epithelial cells dampens acute lung injury in mice. Sci Transl Med 9:
Zemans, Rachel L; Matthay, Michael A (2017) What drives neutrophils to the alveoli in ARDS? Thorax 72:1-3